Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9271706 | Osteoarthritis and Cartilage | 2005 | 8 Pages |
Abstract
Compared to the untreated ACLX condition, administering bisphosphonate immediately after loss of the ACL conserved bone mineral at the MCL enthesis, suggesting the potential to therapeutically influence joint-complex laxity and OA progression.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
M.R. Ph.D., J.M. Ph.D., D.M.L. B.Sc., B. Ph.D., D.A. M.D., R.C. M.D., R.F. Ph.D.,